CLC number: R655.8
On-line Access: 2024-08-27
Received: 2023-10-17
Revision Accepted: 2024-05-08
Crosschecked: 0000-00-00
Cited: 0
Clicked: 5482
Xu Zhi-hao, Wang Chun-fu, Zhang Yue-qin, Shen Hua-hao, Xu Feng. A case of chylothorax treated curatively with Sapylin, a streptococcus preparation[J]. Journal of Zhejiang University Science B, 2007, 8(12): 885-887.
@article{title="A case of chylothorax treated curatively with Sapylin, a streptococcus preparation",
author="Xu Zhi-hao, Wang Chun-fu, Zhang Yue-qin, Shen Hua-hao, Xu Feng",
journal="Journal of Zhejiang University Science B",
volume="8",
number="12",
pages="885-887",
year="2007",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.2007.B0885"
}
%0 Journal Article
%T A case of chylothorax treated curatively with Sapylin, a streptococcus preparation
%A Xu Zhi-hao
%A Wang Chun-fu
%A Zhang Yue-qin
%A Shen Hua-hao
%A Xu Feng
%J Journal of Zhejiang University SCIENCE B
%V 8
%N 12
%P 885-887
%@ 1673-1581
%D 2007
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.2007.B0885
TY - JOUR
T1 - A case of chylothorax treated curatively with Sapylin, a streptococcus preparation
A1 - Xu Zhi-hao
A1 - Wang Chun-fu
A1 - Zhang Yue-qin
A1 - Shen Hua-hao
A1 - Xu Feng
J0 - Journal of Zhejiang University Science B
VL - 8
IS - 12
SP - 885
EP - 887
%@ 1673-1581
Y1 - 2007
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.2007.B0885
Abstract: chylothorax is an uncommon disease where fatty fluid accumulates within the chest cavity. Conservative management, including repeated thoracentesis or pleurodesis, seems to be suitable to most cases. Herein, we present a case of efficacious pleurodesis by intrapleural injection of sapylin, a streptococcus preparation, for the treatment of chylothorax. A 52-year-old non-smoking female farmer was diagnosed as idiopathic chylothorax after we ruled out possible causes including chest trauma, lymphoma, lung cancer, filariasis, tuberculosis, and etc. Two-time intra-thoracic injection of 3 Klinische Einheit (KE) sapylin achieved rapid and effective control of chylothorax with no severe side effects. sapylin may facilitate pleurodesis by producing a strong inflammatory response.
[1] Adachi, H., Hashimoto, T., Komiyama, M., Miyao, Y., Sudou, A., Nakamura, H., Matuoka, T., 2004. Lymphangioleiomyomatosis (LAM) causing chylothorax. Nihon Kokyuki Gakkai Zasshi, 42(1):80-83 (in Japanese).
[2] Dikensoy, O., Light, R.W., 2005. Alternative widely available, inexpensive agents for pleurodesis. Curr. Opin. Pulm. Med., 11(4):340-344.
[3] Duffy, B.M., Manon, R., Patel, R.R., Welsh, J.S., 2005. A case of Gorham’s disease with chylothorax treated curatively with radiation therapy. Clin. Med. Res., 3(2):83-86.
[4] Fujimura, S., Kondo, T., 2000. The lung transplantation has come to be done in Japan. Kyobu Geka, 53(12):986-991 (in Japanese).
[5] Fujino, A., Moriya, Y., Morikawa, Y., Hoshino, K., Watanabe, T., Shimojima, N., Kitajima, M., 2003. A role of cytokines in OK-432 injection therapy for cystic lymphangioma: an approach to the mechanism. J. Pediatr. Surg., 38(12):1806-1809.
[6] Jimenez, C.A., Mhatre, A.D., Martinez, C.H., Eapen, G.A., Onn, A., Morice, R.C., 2007. Use of indwelling pleural catheter for the management of recurrent chylothorax in patients with cancer. Chest, 132(5):1584-1590.
[7] Koga, K., Mita, Y., Dobashi, K., Masuo, T., Aihara, M., Shimizu, Y., Umegae, Y., Mori, M., 1999. Lung cancer with chylothorax successfully treated by chemical pleurodesis with OK-432. Nihon Kokyuki Gakkai Zasshi, 37(8):627-630 (in Japanese).
[8] Laranne, J., Keshi-Nisula, L., Rautio, R., Rautiainen, M., Airaksinen, M., 2002. OK-432 (Picibanil) therapy for lymphangiomas in children. Eur. Arch. Otorhinolaryngol., 259(5):274-278.
[9] Ogita, S., Tsuto, T., Nakamura, K., Deguchi, E., Tokiwa, K., Iwai, N., 1996. OK-432 therapy for lymphangioma in children: why and how does it work? J. Pediatr. Surg., 31(4):477-480.
[10] Shimizu, J., Hayashi, Y., Oda, M., Morita, K., Arano, Y., Nagao, S., Murakami, S., Urayama, H., Watanabe, Y., 1994. Treatment of postoperative chylothorax by pleurodesis with the streptococcal preparation OK-432. Thorac. Cardiovasc. Surg., 42(4):233-236.
[11] Tan, C., Sedrakyan, A., Browne, J., Swift, S., Treasure, T., 2006. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur. J. Cardiothorac. Surg., 29(5):829-838.
[12] Tsukihara, A., Tanemura, M., Suzuki, Y., Sato, T., Tanaka, T., Suzumori, K., 2004. Reduction of pleural effusion by OK-432 in a fetus complicated with congenital hydrothorax. Fetal Diagn. Ther., 19(4):327-331.
Open peer comments: Debate/Discuss/Question/Opinion
<1>